Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) Director Nicholas Dominic Cortezi sold 10,485 shares of the company’s stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total transaction of $682,783.20. Following the sale, the director now directly owns 11,109 shares in the company, valued at approximately $723,418.08. This trade represents a 48.56 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Nicholas Dominic Cortezi also recently made the following trade(s):
- On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.35, for a total transaction of $2,322,250.00.
- On Friday, January 17th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.15, for a total transaction of $2,350,250.00.
- On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00.
- On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96.
- On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total transaction of $5,915.00.
- On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.17, for a total transaction of $2,280,950.00.
- On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total transaction of $2,334,850.00.
- On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00.
Ryan Specialty Stock Performance
NYSE:RYAN opened at $63.27 on Friday. The firm has a market cap of $16.57 billion, a PE ratio of 82.16, a price-to-earnings-growth ratio of 1.14 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a fifty-two week low of $42.21 and a fifty-two week high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The business has a 50 day moving average price of $67.34 and a 200-day moving average price of $66.21.
Ryan Specialty Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.
Institutional Trading of Ryan Specialty
A number of institutional investors have recently made changes to their positions in RYAN. Principal Financial Group Inc. lifted its stake in Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after acquiring an additional 509,548 shares during the period. Jennison Associates LLC lifted its stake in Ryan Specialty by 60.2% in the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock worth $68,054,000 after acquiring an additional 385,366 shares during the period. Eagle Asset Management Inc. lifted its stake in Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after acquiring an additional 335,180 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Ryan Specialty by 43.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock worth $62,286,000 after acquiring an additional 286,380 shares during the period. Finally, Driehaus Capital Management LLC purchased a new stake in Ryan Specialty in the second quarter worth $16,313,000. Hedge funds and other institutional investors own 84.82% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on RYAN shares. Barclays upped their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. Morgan Stanley started coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective on the stock. The Goldman Sachs Group upped their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 14th. Finally, Bank of America upped their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Ryan Specialty presently has an average rating of “Hold” and an average target price of $74.40.
Read Our Latest Stock Report on RYAN
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More
- Five stocks we like better than Ryan Specialty
- About the Markup Calculator
- Bloom Energy: Powering the Future With Decentralized Energy
- Dividend Payout Ratio Calculator
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Health Care Stocks Explained: Why You Might Want to Invest
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.